Myelofibrosis-type megakaryocyte dysplasia (MTMD) as a distinct category of BCR::ABL-negative myeloproliferative neoplasms. Challenges and perspectives

In this Perspective, we discuss criteria for defining a new disease entity or variant of a recognized disease or disorder. We do so in the context of the current topography of the BCR::ABL-negative myeloproliferative neoplasms (MPNs) where two new variants are reported: clonal megakaryocyte dysplasi...

Descripción completa

Detalles Bibliográficos
Autores principales: Barosi, Giovanni, Rosti, Vittorio, Gale, Robert Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079530/
https://www.ncbi.nlm.nih.gov/pubmed/36871061
http://dx.doi.org/10.1038/s41375-023-01861-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079530/
https://www.ncbi.nlm.nih.gov/pubmed/36871061
http://dx.doi.org/10.1038/s41375-023-01861-9

Ejemplares similares